revolution in decision making
Next generation clinical decision support based on predictive analytics
NeoPrediX introduces a new generation of clinical decision support software to personalize and optimize women's health and neonatal care.
Experience the breakthrough in women and children's health. By detecting health risks early on, clinicians can empower informed care decisions for mothers and their children worldwide. This advancement aligns with efforts to improve outcomes, prioritize patient safety, and streamline healthcare costs for hospitals and patients alike. Reach out to the NeoPrediX team today to explore how your institution can proactively advance practices using personalized medicine.
Our Products and Projects
Learn more about our ongoing projects. Join us on our journey to improve women's health and neonatal care.
Bilirubin Prediction Software NeoprediX B.1
Preeclampsia Project
OUR MISSION
We decipher patient data into an
intuitive, scientifically validated forecast to support
clinical decision making.
OUR VISION
We support individualized
healthcare early in life.
The team of experts
Experience for progress -
a highly qualified leadership team
Thorsten Waloschek
CEO
Senior industry executive
President of Draeger Medical Neonatal Care and Vice President of Draeger Medical USA
Head of marketing and new business development at NATUS
Co-founder of InfanDx
Jörg Schmidt
CFO
Senior financial executive in Life Sciences and MedTech industries
Experience at Ernst & Young
Focus on bringing innovative companies and their products to market successfully
Sebastian Kässner
Head of Sales and Marketing
Senior executive with extensive international experience in healthcare sales and marketing
Start-up entrepreneur in healthcare and hygiene management
SLM Solutions AG, Paul Hartmann AG, Dräger AG, TriOptoTec GmbH
Gilbert Koch
Clinical Pharmacologist
Senior Research Fellow in Pediatric Clinical Pharmacology, University of Basel, UKBB
Adjunct Assistant Professor, State University of New York at Buffalo – School of Pharmacy with >10 years of experience in pharmacokinetic and pharmacodynamic modeling
STRATEGIC ADVISORS
Advisory Board
Prof. Julia Vogt
ETH Zurich, Switzerland
Senior industry executive
Professor of Computer Science at ETH Zurich
Expert in machine learning for clinical data analysis and precision medicine
Prof. John van den Anker
Children’s National Medical Center
Director Chief of Clinical Pharmacology
Professor of Pediatrics at George Washington University
Past Distinguished Professor in Pediatric Pharmacology and Pharmacometrics at the University of Basel Children’s Hospital
Prof. Sotirios Fouzas
University of Patras, Greece
Professor of Pediatrics with specialty in pediatric respiratory medicine
Driven to change the way neonatology is currently practiced
Dr. Jonathan Palma
Orlando Health Winnie Palmer Hospital
Doctor of neonatology and perinatal medicine at Winnie Palmer Hospital for Women & Babies (NICU)
Clinical informaticist at Orlando Health
Newborn intensive care and enhancements to patient care quality and provider experience
Supervisory Board
Christine Storm
Germany
Senior industry executive
Business leader virtual care solutions at Philips
Expertise in scale-up of start ups
Dr. Volker Pfahlert
Germany
Entrepreneur
Former CEO of Numares AG (retired) and Draeger Medical
Dr. Gerhard Ries
Switzerland
Serial entrepreneur
CEO Kineo Finance
Investor
Arne Kirchner
Switzerland
Founder of Alp Financial Services
Asset management
Investment banking
Investor
Marc Pfister
Switzerland
Clinician, researcher, innovator and entrepreneur
Head of the department of pharmacometrics at the University Children’s Hospital in Basel, Switzerland
Experience at Sanofi-Aventis, Bristol-Myers Squibb, University of Basel
Sven Wellmann
Germany
Medical Director Dept. of Neonatology and Perinatal Center Regensburg
Leading researcher
Experience at Charité, UKBB Basel, University of Zurich, University of Regensburg
Career Opportunities
Join our growing team and design a future of medicine!
Spun off successfully from the University of Basel, NeoPredix is a young and innovative startup in the medical technology software field. We are developing new, individualized treatment solutions to enhance perinatal and neonatal care. A diverse and motivated team, we are looking for independent, self-motivated individuals who are passionate about using software to improve the lives of children and their families. If this intrigues you, please explore our options below, reach out to us on LinkedIn, or send us your resume at
CONNECT WITH US
Learn more about NeoPredix B.1
by contacting us
NeoPrediX AG (Switzerland)
Aeschengraben 20, 4051 Basel, Switzerland
Executive Team: Jörg Schmidt, Prof. Dr. Marc Pfister , Prof. Dr. Sven Wellmann
Registered office: Basel
Commercial register number CH-270.3.016.001-3
Chairman of the board: Dr. Gerhard Ries
NeoPrediX USA, Inc. (US)
110 E Broward Blvd #1700
Fort Lauderdale, FL 33301, United States
Phone: +1 (954)-315-3884
NeoPrediX AG (Germany)
Franz-Mayer-Straße 1, 93053 Regensburg
Excecutive Board: Thorsten Waloschek (chairman), Jörg Schmidt
Registered Office: Regensburg
Commercial register number: HRB 18679
Supervisory Board: Dr. Volker Pfahlert (chairman), Arne Kirchner, Prof. Dr. Marc Pfister, Dr. Gerhard Ries, Prof. Dr. Sven Wellmann
